期刊
JOURNAL OF BIOMATERIALS APPLICATIONS
卷 37, 期 3, 页码 493-501出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/08853282221102673
关键词
Magnetic resonance imaging; myocardial infarction; nanoparticles; MnCO3; albumin
资金
- Scientific Research Common Program of Beijing Municipal Commission of Education [KM202010025028]
A new type of nanoparticles as an MRI contrast agent for accurate detection of myocardial infarction has been developed. The nanoparticles showed excellent chemical stability and targeting capability, and exhibited low cytotoxicity to cardiomyocytes and good hemocompatibility. Therefore, these nanoparticles have great potential for sensitive and specific detection of the infarcted regions during acute myocardial ischemia/reperfusion injury.
Myocardial infarction (MI) is a major cause of death worldwide. Early and precise diagnosis of myocardial viability after MI is extremely important for effective treatment and prognosis evaluation. Herein, we developed the BSA-templated manganese carbonate (MnCO3@BSA) nanoparticles as an MR imaging contrast agent for accurate detection of the infarcted regions. The chemophysical features, targeting capability toward the infarct, and biocompatibility were evaluated. The nanoparticles showed superior chemical stability. In vitro study suggested that the MnCO3@BSA nanoparticles do not enter normal cardiomyocytes. MR imaging indicated that the MnCO3@BSA with a high longitudinal (r( 1 )) relaxivity of 5.84 mM(-1)s(-1) at physiological condition specifically accumulated into the infarcted regions of myocardial ischemia/reperfusion (I/R) mice. In addition, the MnCO3@BSA nanoparticles exhibited low cytotoxicity to cardiomyocytes, no damage to organs and good hemocompatibility. Thereby, the MnCO3@BSA nanoparticles manifested great potential as an extracellular contrast agent of MR imaging for sensitive and specific detection of the infarcted regions during acute myocardial I/R injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据